Evidence map›Paper›PMID 30864021›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2019

Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in Spain.

J L Cruz-Bermúdez, C Parejo, F Martínez-Ruíz, J C Sánchez-González, A Ramos Martín-Vegue, A Royuela, A Rodríguez-González, E Menasalvas-Ruiz, M Provencio

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Quality of care assessment for non-small cell lung cancer patients: transforming routine care data into a continuous improvement system.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J L Cruz-BermúdezInformation Technologies Department, Puerta de Hierro-Majadahonda University Hospital, Universidad Politécnica de Madrid, Madrid, Spain. jlcruz@idiphim.org.ORCID http://orcid.org/0000-0001-5650-1160
C ParejoMedical Oncology Department, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain.
F Martínez-RuízFacultad de Matemáticas, Universidad de Valencia, Valencia, Spain.
J C Sánchez-GonzálezMedical Oncology Department, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain.
A Ramos Martín-VegueAdmission and Clinical Documentation Department, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain.
A RoyuelaBiostatistics Department, Biomedical Sciences Research Institute Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain.
A Rodríguez-GonzálezCentro de Tecnología Biomédica, Universidad Politécnica de Madrid, Madrid, Spain.
E Menasalvas-RuizCentro de Tecnología Biomédica, Universidad Politécnica de Madrid, Madrid, Spain. ernestina.menasalvas@ctb.upm.es.
M ProvencioMedical Oncology Department, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain. mariano.provencio@salud.madrid.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOur primary goal was to study the use of outpatient attendances by lung cancer patients in Hospital Universitario Puerta de Hierro Majadahonda (HUPHM), Spain, by leveraging our Electronic Patient Record (EPR) and structured clinical registry of lung cancer cases as well as assessing current Data Science methods and tools. METHODS/PATIENTS: We applied the Cross-Industry Standard Process for Data Mining (CRISP-DM) to integrate and analyze activity data extracted from the EPR (9.3 million records) and clinical data of lung cancer patients from a previous registry that was curated into a new, structured database based on REDCap. We have described and quantified factors with an influence in outpatient care use from univariate and multivariate points of view (through Poisson and negative binomial regression).

resultsThree cycles of CRISP-DM were performed resulting in a curated database of 522 lung cancer patients with 133 variables which generated 43,197 outpatient visits and tests, 1538 ER visits and 753 inpatient admissions. Stage and ECOG-PS at diagnosis and Charlson Comorbidity Index were major contributors to healthcare use. We also found that the patients' pattern of healthcare use (even before diagnosis), the existence of a history of cancer in first-grade relatives, smoking habits, or even age at diagnosis, could play a relevant role.

conclusionsIntegrating activity data from EPR and clinical structured data from lung cancer patients and applying CRISP-DM has allowed us to describe healthcare use in connection with clinical variables that could be used to plan resources and improve quality of care.

Indexed as

Age FactorsAmbulatory CareAnalysis of VarianceDatabases, FactualData MiningData ScienceElectronic Health RecordsEmergency Service, HospitalFemaleHealth Services Needs and DemandHospitalizationHospitals, TeachingHumansLung NeoplasmsMaleRegistriesCRISP-DMData miningData ScienceHealthcare useLung cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.